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How to calculate the consumption of volatile anaesthetics from agent concentration 
and fresh gas flow 
 
 
 
Background: The assessment of volatile agents’ consumption is usually performed by weighing 
vaporisers before and after use. This method is technically demanding and unavailable for 
retrospective analysis of anaesthesia records. Therefore a method based on calculations from fresh 
gas flow and agent concentration is presented here. 
Methods:. The herein presented calculation method enables a precise estimation of ongoing or past 
anaesthesias when average fresh gas flow and average volatile agent concentration throughout the 
whole time period of anaesthetic gas delivery is known. Additionally, the vapor amount deriving from 1 
ml fluid volatile agent has to be known. The necessary formulas for these calculations are presented 
herein for four agents and exemplary calculations simulating clinical dosages are performed. 
Results: The calculation of volatile agent vapour deriving from 1 ml of fluid agent is presented: 
halothane 229 ml, isoflurane 195 ml, sevoflurane 184 m and desflurane 210 ml. These constants are 
used in 4 fictitious clinical cases to exemplify the calculation of volatile agent consumption in daily 
routine. 
Conclusions:  By application of the presented specific volatile agent constants and equations, it 
becomes easy to calculate volatile agent consumption if the fresh gas flows and the resulting inhaled 
concentration of the volatile agent are known. By this method both is possible, to extract data about 
volatile agent consumption both ways: a) retrospectively from sufficiently detailed and accurate 
anesthesia recordings, as well as b) by application of this method in a prospective setting. Therefore, 
this method is a valuable contribution to perform pharmaco-economical surveys. 
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Introduction 
 
The knowledge about the consumption of volatile agents during anaesthesia and its 
pharmacoeconomical implications gains increasing relevance and attention.1,2  The easiest way to 
assess the consumption of volatile anaesthetics is to weigh the vaporiser before and after anaesthesia 
and to take the difference (plus the eventually added refilled volumes during the ongoing anaesthesia) 
as the consumed amount. This method has been widely used for various drug consumption and 
pharmaco-economic investigations.3,4  A certain technical problem derives from the necessity for a 
very precise balance that has a wide range of measurement. Usually the larger the measurement 
range, the less is the resolution for small differences between the measured objects. A vaporiser 
weighs up to 5 kg, while the differences produced by the prevailing levels of its volatile anaesthetic 
content remains in the range of a few grams. Besides this technical limitation, this method can be only 
adopted if the assessment is planned in advance and one has the opportunity and necessary time to 
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perform pre- and post-anaesthesia measurements. Due to the limited availability of the mentioned 
equipment as well as the necessity to plan the measurements individually in advance, this weighing 
method remains limited to a reduced number of cases. 
 
However, since roughly two decades we have a reliable method for the assessment of volatile agents 
consumption that can be applied if a few basic data of the already carried out such as the settings for 
both, the fresh gas flow (FGF) and the volatile agent concentration in the fresh gas, as well as the time 
course of these parameters.5,6  Additional concomitant conditions that have to be taken into 
consideration are the average temperature of the vaporiser during the procedure, and the specific 
amount of anaesthetic vapor that can be maximally drawn from 1 ml of fluid agent; the calculation of 
the latter for 4 volatile agents under standard conditions is presented further down. The vaporiser 
temperature can be approximated to be roughly 2°C below the prevailing room temperature, while the 
amount of anaesthetic vapor at complete saturation of the fresh gas is a constant that can be obtain 
by a few preparatory calculations. In the following, the calculation of volatile anaesthetic consumption 
from anaesthesia records is demonstrated. 
 
Methods 
 
As being an investigation based on physical principles and calculations without involvement of patients 
and/or personnel, there is no need for approval by an Ethical Committee. The herein presented 
assessment of volatile anaesthetic consumption relies on the assumption, that if the amount of fresh 
gas and its content of volatile anaesthetic is known, one can calculate how much of the volatile 
anaesthetic in its original fluid form has been drawn from the vaporiser. The first step is to determine 
the amount of anaesthetic vapor at complete saturation for each specific volatile agent. For this 
purpose, this equation has to be applied: 
 
𝐹𝑙𝑢𝑖𝑑 𝑉𝐴 (𝑚𝑙) = 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑤𝑒𝑖𝑔ℎ𝑡1 ∙ 𝐴𝑣𝑜𝑔𝑎𝑑𝑟𝑜′𝑠 𝑔𝑎𝑠 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡2 ∙ (273 + 𝑡𝑒𝑚𝑝𝑒𝑟𝑎𝑡𝑢𝑟𝑒)3 
𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡4  ∙  273  
 
1 Specific weight for volatile anaesthetics in g/ml is as follows: halothane 1.87, isoflurane 1.49, 
sevoflurane 1.53, and desflurane 1.47.7,8 
 
2 Avogadro’s gas constant states that at a standard atmospheric pressure of 760 mmHg (at sea level) 
and at a temperature of 0°C = 273 °K one mole of any gas consists of 6.023 x 1023 molecules which in 
turn occupy a volume of 22’400 ml. This is the same for all gases at STPD conditions, and also in the 
case of all volatile anaesthetics. STPD means “standard temperature, standard pressure, dry”, which 
is given for a volume of gas at 0° C and 760 torr, and that contains no water vapor. 
 
3 The temperature of the vaporiser is close to room temperature. Due to the loss of energy during 
evaporation there is a tendency of cooling of the vaporiser, which is counteracted by its inbuilt high 
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temperature conductibility. It’s reasonable to subtract 2°C from the prevailing room temperature 
(personal experience), then the result is to be added to 273°K. 
 
4 Molecular weights for volatile anaesthetics are as follows: halothane 197, isoflurane 184, sevoflurane 
200, and desflurane 168.7,8 
 
Having these four items (and assuming a room temperature of 22°C and a vaporiser temperature of 
20°C), we obtain the saturated vapor volumes from the evaporation of 1 ml fluid volatile anaesthetics: 
 
𝐻𝑎𝑙𝑜𝑡ℎ𝑎𝑛𝑒 𝑣𝑎𝑝𝑜𝑟 𝑣𝑜𝑙𝑢𝑚𝑒 = 1.87 ∙ 22′400 ∙ (273 + 20) 197 ∙  273 = 229 𝑚𝑙 
 
 
𝐼𝑠𝑜𝑓𝑙𝑢𝑟𝑎𝑛𝑒 𝑣𝑎𝑝𝑜𝑟 𝑣𝑜𝑙𝑢𝑚𝑒 = 1.49 ∙ 22′400 ∙ (273 + 20) 184 ∙  273 = 195 𝑚𝑙 
 
 
𝑆𝑒𝑣𝑜𝑓𝑙𝑢𝑟𝑎𝑛𝑒 𝑣𝑎𝑝𝑜𝑟 𝑣𝑜𝑙𝑢𝑚𝑒 = 1.53 ∙ 22′400 ∙ (273 + 20) 200 ∙  273 = 184 𝑚𝑙 
 
 
𝐷𝑒𝑠𝑓𝑙𝑢𝑟𝑎𝑛𝑒 𝑣𝑎𝑝𝑜𝑟 𝑣𝑜𝑙𝑢𝑚𝑒 = 1.47 ∙ 22′400 ∙ (273 + 20) 168 ∙  273 = 210 𝑚𝑙 
 
After obtaining these constants, the next step is to include these values into a formula that considers 
the settings for the FGF, as well as for the volatile agent concentrations that have been used 
throughout the course of the investigated anaesthesia. For volatile agent concentrations, measured 
values are to be preferred 9, but if these are unavailable, the vaporiser settings can be used as well, 
albeit with a lesser degree of precision, since usually the output of vaporisers is lower than the set 
level 10. Finally, for our calculations we need average FGF and anaesthetic agent concentrations. 
Usually, during an anaesthesia, both,  FGF and even more so the volatile agent concentrations are 
subjected to multiple changes, which may happen independently of each other. Therefore, first the 
whole anaesthesia time duration has to be broken down into segments with constant settings, and 
their resulting products must be cumulated to obtain the average values of the entire anaesthesia. To 
illustrate this measure, here come 4 examples of fictitious (but realistic) inhaled anaesthesia 
applications which in the “Results” section will be used to exemplify the calculation of the ensuing 
volatile agent consumptions: 
 
Case A. 
A halothane anaesthesia of 40 minutes duration. The FGF settings (in L/min) and their durations 
(in min) were: 12 for 15 min, and 6 for 25 min. The concentration changes (in Vol%) were: 2 for 
10 min, 1.2 for 20 min, 0.8 for 10 min. 
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 Case B. 
An isoflurane anaesthesia of 60 minutes duration. The FGF settings (in L/min) and their durations 
(in min) were: 6 for 5 min, 3 for 20 min, 6 for 5 min, and 2 for 30 min. The concentration changes 
(in Vol%) were: 2.8 for 10 min, 1.6 for 15 min, and 2 for 35 min. 
 
Case C. 
A sevoflurane anaesthesia of 90 minutes duration. The FGF settings (in L/min) and their 
durations (in min) were: 10 for 10 min, 3 for 20 min, 4 for 10 min, and 1.5 for 50 min. The 
concentration changes (in Vol%) were: 2.5 for 5 min, 1.8 for 15 min, 1.2 for 50 min, and 0.9 for 20 
min. 
 
Case D. 
A desflurane anaesthesia of 120 minutes duration. The FGF settings (in L/min) and their 
durations (in min) were: 7 for 10 min, and 0.5 for 110 min. The concentration changes (in Vol%) 
were: 8 for 5 min, 6 for 100 min, and 1 for 15 min. 
 
The usual high FGF settings at the end of anaesthesia with the scope of rapid removal of the residual 
volatile agent from the body are here ignored since during this measure no volatile agent consumption 
from the otherwise closed vaporiser occurs anymore. The hereby removed agent has already been 
included into the consumption calculation while it was delivered into the circuit. The time courses of 
the FGF and volatile agent setting examples are illustrated in Fig. 1. 
 
 
Fig. 1. Visual display of the time courses for fresh gas flows (FGF) and volatile agent concentrations in 
four different examples as they usually appear in anaesthesia records. Such displays are sufficient to 
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extract the necessary data for the calculation of mean FGF and volatile agent concentrations. On the 
right margin the resulting average values are included. 
 
 
Results 
The calculation of mean FGF and volatile anaesthetic concentrations for each case follows here. First 
the product of FGF (in Liters) and its time segment (in minutes) is obtained.  
 
Case A (stepwise calculation as example): 
Total FGF: (12 x 15) + (6 x 35) = 330 L; Divided by the total duration of 40 min, we obtain a 
mean FGF by having 330 : 40 = 8.25 L/min 
 
This is followed by the product of agent concentrations (in Vol%) and their time segment (in minutes):  
 
Total Vol%: (2 x 10) + (1.2 x 20) + (0.8 x 10) = 52. Mean Vol% results from 52 : 40 = 1.3 Vol%. 
 
Analog calculations for the other three agents result in: 
 
Case B 
Mean FGF = 3 L/min 
Mean Vol% = 2.03 Vol% 
 
Case C 
Mean FGF = 3.06 L/min 
Mean Vol% = 1.31 Vol% 
 
Case D 
Mean FGF = 1.05 L/min 
Mean Vol% = 5.46 Vol% 
 
These mean values for FGF have to be converted into milliliters/min, and inserted together with the 
mean volatile agent concentrations (Fig. 1), the duration of anaesthetic gas delivery (min) and the 
specific constants for saturated gas for each volatile anaesthetic into this equation: 
 
𝐹𝑙𝑢𝑖𝑑 𝑣𝑜𝑙𝑎𝑡𝑖𝑙𝑒 𝑎𝑔𝑒𝑛𝑡 =  𝑚𝑒𝑎𝑛 𝐹𝐺𝐹 (𝑚𝑙 min )  ∙ 𝑚𝑒𝑎𝑛 𝑎𝑔𝑒𝑛𝑡 𝑐𝑜𝑛𝑐. (𝑉𝑜𝑙%)  ∙ 𝐴𝑛𝑎𝑒𝑠𝑡ℎ.𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 (min ) ⁄
𝑆𝑎𝑡𝑢𝑟𝑎𝑑𝑒𝑑 𝑔𝑎𝑠 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝑙) ∙ 100 (𝑉𝑜𝑙%) = 𝑚𝑙 
 
This is presented for all four exemplary cases: 
 
Case A 
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𝐻𝑎𝑙𝑜𝑡𝑎𝑛𝑒 𝑓𝑙𝑢𝑖𝑑 𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 =  8250 𝑚𝑙 min ∙ 1.3 𝑉𝑜𝑙% ∙ 40 min⁄229 𝑚𝑙 ∙ 100 𝑉𝑜𝑙% = 18.7 𝑚𝑙 
 
 
Case B 
𝐼𝑠𝑜𝑓𝑙𝑢𝑟𝑎𝑛𝑒 𝑓𝑙𝑢𝑖𝑑 𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 =  3000 𝑚𝑙 min ∙ 2.03 𝑉𝑜𝑙% ∙ 60 min⁄195 𝑚𝑙 ∙ 100 𝑉𝑜𝑙% = 18.8 𝑚𝑙 
 
Case C 
𝑆𝑒𝑣𝑜𝑓𝑙𝑢𝑟𝑎𝑛𝑒 𝑓𝑙𝑢𝑖𝑑 𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 =  3060 𝑚𝑙 min ∙ 1.31 𝑉𝑜𝑙% ∙ 90 min⁄184 𝑚𝑙 ∙ 100 𝑉𝑜𝑙% = 19.6 𝑚𝑙 
 
Case D 
𝐷𝑒𝑠𝑓𝑙𝑢𝑟𝑎𝑛𝑒 𝑓𝑙𝑢𝑖𝑑 𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 =  1050 𝑚𝑙 min ∙ 5.46 𝑉𝑜𝑙% ∙ 120 min⁄210 𝑚𝑙 ∙ 100 𝑉𝑜𝑙% = 32.7 𝑚𝑙 
 
Having the consumed fluid volatile anaesthetic volumes, it’s easy to calculate the costs. In contrast to 
i.v. anaesthetics where the unused remnant has to be discarded, the residual content of vaporisers is 
no waste and can be used for the next patient. We only need to know the expenditure and price of the 
evaporated agent. In Table 1 the volatile agent market prices for Switzerland (as obtained from the 
hospital’s pharmacy in November 2013) are included and the resulting costs of the four examples are 
displayed. 
 
Time 
segment 
1 2 3 4 5 6 7 
Duration 5 5 10 10 10 30 20 
GF flow 
(ml/min) 
10’000 10’000 3’000 3’000 4’000 1’500 1’500 
VA conc. 
(Vol%) 
2.5 1.8 1.8 1.2 1.2 1.2 1.2 
VA 
consumption 
6.8 4.9 2.9 2.0 2.6 2.9 2.0 
 
Table 1. Results from the costs calculations considering the actual volatile anaesthetic prices and their 
application on the presented cases A to D (as given in November 2013 in Switzerland. Currency 
conversion rates were at the same time: 1.00 CHF = 1.10 US$ = 0.81 EUR). 
 
 
Discussion 
 
The consumption of volatile anaesthetics can be precisely estimated from anaesthesia records if these 
essential data are available: a) the choice of the volatile anaesthetic, b) the applied FGF (with 
knowledge about the durations of its setting variations), and finally c) the applied concentration of the 
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chosen volatile anaesthetic - again with knowledge about the durations of each concentration setting. 
The total anaesthesia time is identical with the sum of the recorded FGF or volatile agent 
concentration time segments. Considerations of uptake of the volatiles into the body or losses through 
leaks in the breathing circuit are irrelevant for this kind of cost calculations since what counts in this 
respect is only the extracted amount from the vaporizer, which is the composition and amount of the 
FGF. 
 
The herein presented approach by calculation from FGF and (preferably) from measured exhaled 
volatile agent concentrations has the big advantage to be applicable without the necessity to have 
sophisticated equipment such as a very precise balance with a large measurement range. Additionally, 
one can assess volatile agent consumptions retrospectively, provided that the recordings are accurate 
and detailed enough. By this it’s theoretically possible to extract data from an unlimited number of 
cases resp. from archived records. 
 
A certain disadvantage of this calculation based method is the initially laborious assessment of the 
mean FGF and agent concentrations by summing up their individual time segments. However, this 
work can be considerably facilitated by using a suitable matrix in a spreadsheet (e.g. in Excel, 
Microsoft, Seattle USA) where one only has to enter the relevant numbers into the matching cells. To 
illustrate such a table, a screenshot from the calculation for the case D is included in Fig. 2. 
 
Fig. 2. Example for a calculation matrix for case C (sevoflurane anaesthesia) as used in Excel 
(Microsoft, Seattle, USA) to obtain the mean fresh gas flow (FGF) and mean volatile agent 
concentration over the total anaesthesia time. In the bottom row are calculated the consumption per 
min and the total consumed volume of the volatile agent. 
 
Another – thanks to this work by now not anymore existing – handicap is to obtain the constants for 
the specific amounts of the most familiar volatile agents indicating the gas volume that result from 
evaporation of 1 ml of each agent. These values have been obtained from known physical attributes 
such as the molecular as well the specific weight of these compounds, and finally by applying 
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Avogadro’s universal gas laws. The resulting constants for the four most widespread volatiles are here 
available: halothane 229 ml, isoflurane 195 ml, sevoflurane 184 m and desflurane 210 ml. However, 
for the sake of accuracy is to be stated, that these constants are valid for “low lands” only (which for 
practical reasons may be acceptable for locations up to 500 m above sea level). For anaesthesia 
practiced at higher altitudes, the figures have to be calculated with altered parameters. 
 
Conclusions 
 
The professional audience has been offered a suitable tool to make precise and relevant 
pharmacoeconomical calculations in their daily business. The hereby presented method is also well 
suitable to estimate the impact of various FGF settings in order to optimise the consumption 
parameters for the involved inhaled anaesthetics and of related equipment.3  An interesting and useful 
expansion of the here stated method would be the simultaneous measurement of inhaled and exhaled 
volatile anaesthetics and to compare the obtained uptake with the calculated delivered amount of that 
agent.2,11  By comparing these parameters, one can deduct the magnitude of unused anaesthetic gas 
and will be able to take measures for minimizing waste and pollution. 
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